Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: Utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining

American Journal of Surgical Pathology

Volumn 32, Issue 7, 2008, Pages 1051-1059

  Weinbreck, Nicolas ^a   Marie, Béatrice ^a   Bressenot, Aude ^a   Montagne, Karine ^a   Joud, Antony ^b   Baumann, Cédric ^c   Klein, Olivier ^b   Vignaud, Jean Michel ^a,c,d  

^a Tumorothèque INCa ^*

^b Departments of Neurosurgery

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d INSERM   (France)

Author keywords

aquaporin1; cytokeratin AE1 AE3; hemangioblastoma; inhibin ; metastatic clear cell renal cellcarcinoma

Indexed keywords

AQUAPORIN 1; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; INHIBIN; MONOCLONAL ANTIBODY D2-40; KERATIN; TUMOR MARKER;

ADULT; ARTICLE; BRAIN TUMOR; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE MARKER; FEMALE; HEMANGIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; TUMOR CELL; WESTERN BLOTTING; ADOLESCENT; AGED; CHEMISTRY; CHILD; DIFFERENTIAL DIAGNOSIS; KIDNEY TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AQUAPORIN 1; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOBLASTOMA; HUMANS; KERATINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 47249159473     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181609d7d     Document Type: Article

References (46)

1. Abou-Hamden A, Koszyca B, Carney PG, et al. Metastasis of renal cell carcinoma to haemangioblastoma of the spinal cord in von Hippel-Lindau disease: case report and review of the literature. Pathology. 2003;35:224-227.
2. Altinoz MA, Santaguida C, Guiot MC, et al. Spinal hemangio-blastoma containing metastatic renal cell carcinoma in von Hippel-Lindau disease. Case report and review of the literature. J Neurosurg Spine. 2005;3:495-500.
3. Andrew SM, Gradwell E. Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haeman-gioblastomas and central nervous system metastases of renal carcinomas. J Clin Pathol. 1986;39:917-919.
4. Avery AK, Beckstead J, Renshaw AA, et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24:203-210.
5. Bailey D, Baumal R, Law J, et al. Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA. 1986;83:5291-5295.
6. Bazille C, Allory Y, Molinie V, et al. Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases. Ann Pathol. 2004;24:395-406.
7. Becker I, Paulus W, Roggendorf W. Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study. Am J Pathol. 1989;134:271-275.
8. Bleistein M, Geiger K, Franz K, et al. Transthyretin and transferrin in hemangioblastoma stromal cells. Pathol Res Pract. 2000;196: 675-681.
9. Bohling T, Plate KH, Haltia MJ, et al. World Health Organization Classification of Tumours. von Hippel-Lindau disease and capillary hemangioblastoma. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2000:223-226.
10. Brown DF, Dababo MA, Hladik CL, et al. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas. Mod Pathol. 1998;11:55-59.
11. Burger PC, Scheithauer BW, Vogel FS. Surgical Pathology of the Nervous System and its Coverings. 3rd ed. New York: Churchill Livingstone; 1991:373-386.
12. Chan CC, Chew EY, Shen D, et al. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease. Mol Vis. 2005;11:697-704.
13. Chen Y, Tachibana O, Oda M, et al. Increased expression of aquaporin 1 in human hemangioblastomas and its correlation with cyst formation. J Neurooncol. 2006;80:219-225.
14. Choi WW, Lewis MM, Lawson D, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol. 2005;18:143-152.
15. Conway JE, Chou D, Clatterbuck RE, et al. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48:55-62.
16. Endo M, Jain RK, Witwer B, et al. Water channel (aquaporin 1) expression and distribution in mammary carcinomas and glioblas-tomas. Microvasc Res. 1999;58:89-98.
17. Feldenzer JA, McKeever PE. Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas. Acta Neuropathol (Berl). 1987;72:281-285.
18. Ficarra V, Righetti R, Martignoni G, et al. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int. 2001;67:130-134.
19. Frank TS, Trojanowski JQ, Roberts SA, et al. A detailed immuno-histochemical analysis of cerebellar hemangioblastoma: an undiffer-entiated mesenchymal tumor. Mod Pathol. 1989;2:638-651.
20. Gouldesbrough DR, Bell JE, Gordon A. Use of immunohistochem-ical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma. J Clin Pathol. 1988;41:861-865.
21. Hamazaki S, Nakashima H, Matsumoto K, et al. Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease. Pathol Int. 2001;51: 948-953.
22. Hoang MP, Amirkhan RH. Inhibin alpha distinguishes hemangio-blastoma from clear cell renal cell carcinoma. Am J Surg Pathol. 2003;27:1152-1156.
23. Hufnagel TJ, Kim JH, True LD, et al. Immunohistochemistry of capillary hemangioblastoma. Immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma. Am J Surg Pathol. 1989;13: 207-216.
24. Jung SM, Kuo TT. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol. 2005;18:788-794.
25. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
26. Khoury JD, Abrahams NA, Levin HS, et al. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann Diagn Pathol. 2002;6:154-158.
27. Lach B, Gregor A, Rippstein P, et al. Angiogenic histogenesis of stromal cells in hemangioblastoma: ultrastructural and immunohis-tochemical study. Ultrastruct Pathol. 1999;23:299-310.
28. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
29. Longatti P, Basaldella L, Orvieto E, et al. Aquaporin 1 expression in cystic hemangioblastomas. Neurosci Lett. 2006;392:178-180.
30. Mazal PR, Stichenwirth M, Koller A, et al. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod Pathol. 2005;18: 535-540.
31. Mills SE, Ross GW, Perentes E, et al. Cerebellar hemangioblastoma: immunohistochemical distinction from metastatic renal cell carcinoma. Surg Pathol. 1990;3:121-132.
32. North PE, Mizeracki A, Mihm MC Jr, et al. GLUT1 immunoreac-tion patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. Clin Neuropathol. 2000;19:131-137.
33. Oshio K, Binder DK, Liang Y, et al. Expression of the aquaporin-1 water channel in human glial tumors. Neurosurgery. 2005;56: 375-381.
34. Picard E, Seguin C, Monhoven N, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancerl Inst. 1999;91:1059-1066.
35. Rasmuson T, Grankvist K, Roos G, et al. Neuroendocrine differentiation in renal cell carcinoma - evaluation of chromogranin A and neuron-specific enolase. Acta Oncol. 1999;38:623-628.
36. Roy S, Chu A, Trojanowski JQ, et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol (Berl). 2005;109:497-502.
37. Saadoun S, Papadopoulos MC, Davies DC, et al. Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancerl. 2002;87:621-623.
38. Schoggl A, Kitz K, Ertl A, et al. Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochir (Wien). 1998;140:549-555.
39. Seizinger BR, Rouleau GA, Ozelius LJ, et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature. 1988;332:268-269.
40. Taki A, Nakatani Y, Misugi K, et al. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Mod Pathol. 1999;12:310-317.
41. Tse JY, Wong JH, Lo KW, et al. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. Am J Clin Pathol. 1997;107: 459-466.
42. Umenishi F, Schrier RW. Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. J Biol Chem. 2003;278:15765-15770.
43. Vatsal DK, Husain M, Husain N, et al. Cerebellar hemangioblas-toma simulating arachnoid cyst on imaging and surgery. Neurosurg Rev . 2002;25:107-109.
44. Verkman AS. Physiological importance of aquaporin water channels. Ann Med. 2002;34:192-200.
45. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, et al. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol. 1997;28:540-543.
46. Wanebo JE, Lonser RR, Glenn GM, et al. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98:82-94.